The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Open Access
- 1 August 1988
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 82 (2) , 579-585
- https://doi.org/10.1172/jci113635
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid inhibitor of tissue plasminogen activator (tPA) and urokinase. Clinical studies suggest that PAI-1 may play a crucial role in the regulation of fibrinolysis. A number of factors modulate PAI-1 activity in endothelial cell culture, and the isolation of PAI-1 cDNA now allows study of PAI-1 regulation at the mRNA level. We examined the effect of endothelial cell growth factor (ECGF) and heparin on PAI-1 expression in human umbilical vein endothelial cell (HUVEC) culture. The addition of ECGF and heparin to HUVEC cultures results in a 3-10-fold decrease in the PAI-1 activity secreted into the conditioned media. This effect is mediated at the mRNA level. A decrease in PAI-1 is also seen with higher concentrations of ECGF alone, but is greatly enhanced by the addition of heparin. No significant change in tPA antigen or mRNA levels was observed.This publication has 45 references indexed in Scilit:
- Effects of endothelial cell growth factor on bone remodelling in vitro.Journal of Clinical Investigation, 1987
- Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencingFEBS Letters, 1986
- A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 1986
- Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.Journal of Clinical Investigation, 1986
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.Journal of Clinical Investigation, 1986
- Human von Willebrand Factor (vWF): Isolation of Complementary DNA (cDNA) Clones and Chromosomal LocalizationScience, 1985
- Studies on the Profibrinolytic Actions of Heparin and Its FractionsSeminars in Thrombosis and Hemostasis, 1985
- POLYPEPTIDE GROWTH FACTORSAnnual Review of Biochemistry, 1984
- Serial propagation of human endothelial cells in vitro.The Journal of cell biology, 1981